Androgens have been suggested to influence breast cancer risk, either by directly binding to androgen receptors and either increasing or decreasing breast cell growth and proliferation, or by binding indirectly, through their conversion to estradiol or competitive binding to ER-α [6]. This evidence concerns the gene ESR1 and breast carcinoma.